{"id":3078,"date":"2024-03-22T16:14:22","date_gmt":"2024-03-22T13:14:22","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3078"},"modified":"2024-03-22T16:14:22","modified_gmt":"2024-03-22T13:14:22","slug":"novartis-asya-pasifik-orta-dogu-ve-afrikadaki-hastalarin-erisim-engellerini-ortadan-kaldirmaya-odaklanan-appis-zirvesini-gerceklestirdi","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3078","title":{"rendered":"Novartis, Asya Pasifik, Orta Do\u011fu ve Afrika’daki Hastalar\u0131n Eri\u015fim Engellerini Ortadan Kald\u0131rmaya Odaklanan APPIS Zirvesi\u2019ni Ger\u00e7ekle\u015ftirdi"},"content":{"rendered":"\n

Novartis\u2019in Hasta \u0130novasyonu ve \u00c7\u00f6z\u00fcmleri i\u00e7in \u0130\u015fbirli\u011fi ve Ortakl\u0131klar platformu olan <\/strong>APPIS<\/strong><\/a> <\/strong>sa\u011fl\u0131k ekosistemindeki \u00f6nemli payda\u015flar\u0131 bir araya getirerek\u00a0Asya Pasifik, Orta Do\u011fu ve Afrika’daki sa\u011fl\u0131k hizmetlerinin daha iyi bir hale gelmesini ama\u00e7l\u0131yor ve bu hedefle her y\u0131l \u00e7evrimi\u00e7i bir zirve d\u00fczenliyor.<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

APPIS 2024 Konseyi taraf\u0131ndan ortakla\u015fa olu\u015fturulan ve Novartis taraf\u0131ndan d\u00fczenlenen 4. geleneksel Hasta \u0130novasyon ve \u00c7\u00f6z\u00fcmleri i\u00e7in \u0130\u015fbirli\u011fi ve Ortakl\u0131klar (APPIS) Zirvesi 19-20 Mart 2024 tarihlerinde ger\u00e7ekle\u015ftirildi. Zirve, Asya Pasifik, Orta Do\u011fu ve Afrika’daki hastalar\u0131n tedaviye eri\u015fiminin \u00f6n\u00fcndeki engelleri ele almak i\u00e7in i\u015f birliklerini kolayla\u015ft\u0131rmay\u0131 ama\u00e7l\u0131yor.<\/p>\n\n\n\n

APPIS, 2021’den bu yana hasta organizasyonlar\u0131, kamu temsilcileri, \u00f6deme kurumlar\u0131 temsilcileri, hekimler ve akademisyenler de dahil olmak \u00fczere 2 binden fazla ki\u015fiyi bir araya getirerek bilgi payla\u015f\u0131m\u0131 yap\u0131lmas\u0131n\u0131 sa\u011flad\u0131 ve hasta inovasyonu ve \u00e7\u00f6z\u00fcmleri konusunda ortakl\u0131klar kurdu. APPIS, y\u0131l boyunca d\u00fczenlenen programlar ve inisiyatifler arac\u0131l\u0131\u011f\u0131yla hasta eri\u015fiminin \u00f6n\u00fcndeki engelleri ele almak i\u00e7in topluluklara bilgi ve ilham vermeyi ve ayn\u0131 zamanda ortak bir hareket olu\u015fturmay\u0131 ama\u00e7l\u0131yor.<\/p>\n\n\n\n

Hastalar i\u00e7in daha iyi sonu\u00e7lar elde etme amac\u0131yla b\u00f6lge \u00e7ap\u0131nda \u00e7evrimi\u00e7i olarak d\u00fczenlenen zirvede sa\u011fl\u0131k uzmanlar\u0131, hasta liderleri, kamu temsilcileri ve sa\u011fl\u0131k gazetecileri de dahil olmak \u00fczere farkl\u0131 \u00fclkelerden 40’\u0131n \u00fczerinde konu\u015fmac\u0131 yer ald\u0131. Zirvede ayr\u0131ca Arap\u00e7a, \u00c7ince, Japonca, Korece, Tayca, T\u00fcrk\u00e7e ve Vietnamca dillerinde simultane terc\u00fcme deste\u011fi de sunuldu. \u00d6nemli oturumlar aras\u0131nda “\u0130\u00e7g\u00f6r\u00fclerin Kilidini A\u00e7mak:  Ger\u00e7ek D\u00fcnya Veri Kullan\u0131m\u0131nda Yenilikler” (<\/em>Julie Cini’nin moderat\u00f6rl\u00fc\u011f\u00fcnde), K\u00fcresel Miras Lideri, S\u0131n\u0131rlar\u0131n \u00d6tesinde Savunuculuk ve N\u00f6roEndokrin Kanser Avustralya CEO’su Meredith Cummins taraf\u0131ndan y\u00f6netilen “Hasta \u00d6z Savunuculu\u011funda Dersler ve Ba\u015far\u0131<\/em>” yer al\u0131yor.<\/p>\n\n\n\n

Program sa\u011fl\u0131k okuryazarl\u0131\u011f\u0131, sa\u011fl\u0131k politikalar\u0131n\u0131n \u015fekillendirilmesi ve gelece\u011fe haz\u0131r olma gibi \u00fc\u00e7 ana temaya odaklanan canl\u0131 panel oturumlar\u0131, sohbetler ve sunumlardan olu\u015ftu.<\/p>\n\n\n\n

Zirvede T\u00fcrkiye\u2019den de iki konu\u015fmac\u0131 yer ald\u0131. Kardiyovask\u00fcler Sa\u011fl\u0131\u011f\u0131 \u0130yile\u015ftirmede Giyilebilir Teknolojilere Bak\u0131\u015f oturumunda s\u00f6z alan Turkcell Teknoloji Uluslararas\u0131 Ar-Ge Proje \u0130\u015fbirlikleri Koordinat\u00f6r\u00fc I\u015f\u0131l \u00d6zkan ve Ko\u00e7 \u00dcniversitesi T\u0131p Fak\u00fcltesi Kardiyoloji B\u00f6l\u00fcm\u00fc \u00d6\u011fretim \u00dcyesi Prof. Dr. Dilek Ural \u201cGiyilebilir Sa\u011fl\u0131k Teknolojilerinin Kalp Sa\u011fl\u0131\u011f\u0131 \u0130\u00e7in \u00d6nemli Hasta \u0130\u00e7g\u00f6r\u00fclerini Nas\u0131l Olu\u015fturmaya Yard\u0131mc\u0131 Oldu\u011funa Dair Bir Vaka \u00c7al\u0131\u015fmas\u0131\u201d isimli \u00e7al\u0131\u015fmalar\u0131n\u0131 sundular.<\/p>\n\n\n\n

Sa\u011fl\u0131k ekosistemindeki payda\u015flar\u0131 da bir araya getirerek, \u00f6nemli sorunlar\u0131 belirlemeyi ve uygulanabilir \u00e7\u00f6z\u00fcmleri \u00f6nceliklendirmeyi ama\u00e7layan APPIS platformu, ancak bu yolla ortak \u00e7\u00f6z\u00fcmler bulunabilece\u011fine ve harekete ge\u00e7ilebilece\u011fine inan\u0131yor. Novartis taraf\u0131ndan d\u00fczenlenen ve finanse edilen APPIS platformu, y\u0131ll\u0131k b\u00f6lgesel APPIS Zirvesi, APPIS \u0130novat\u00f6r Program\u0131, \u00e7evrimi\u00e7i Bir Kaynak Merkezi ve yerel \u00f6neme sahip sa\u011fl\u0131k konular\u0131n\u0131 ele alan APPISx gibi bile\u015fenleri i\u00e7eriyor.<\/p>\n","protected":false},"excerpt":{"rendered":"

Novartis\u2019in Hasta \u0130novasyonu ve \u00c7\u00f6z\u00fcmleri i\u00e7in \u0130\u015fbirli\u011fi ve Ortakl\u0131klar platformu olan APPIS sa\u011fl\u0131k ekosistemindeki \u00f6nemli payda\u015flar\u0131 bir araya getirerek\u00a0Asya Pasifik, Orta Do\u011fu ve Afrika’daki sa\u011fl\u0131k hizmetlerinin daha iyi bir hale gelmesini ama\u00e7l\u0131yor ve bu hedefle her y\u0131l \u00e7evrimi\u00e7i bir zirve d\u00fczenliyor.<\/p>\n","protected":false},"author":1,"featured_media":3079,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3078"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3078"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3078\/revisions"}],"predecessor-version":[{"id":3081,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3078\/revisions\/3081"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3079"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}